Setting

Global Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Region: Trend Forecast and Growth Opportunity

Published: 30 Apr 2023 | Report Code: 10248436 | Pages: 241

Global Clinical Trials Market will reach $79,977.1 million by 2031, growing by 7.0% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence of chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 148 tables and 111 figures, this 241-page report “Global Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Global Clinical Trials Market and all its sub-segments through extensively detailed classifications.

 

Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

 

In-depth qualitative analyses include the identification and investigation of the following aspects:
•  Market Structure 
•  Growth Drivers 
•  Restraints and Challenges
•  Emerging Product Trends & Market Opportunities
•  Porter’s Five Forces

 

The trend and outlook of global market is forecast in an optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Global Clinical Trials Market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Region.

 

Based on Product Category, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section. 
•  Trials of Drugs
    o  Small Molecule Drugs
    o  Vaccines
    o  Cell & Gene Therapy
    o  Other Drugs
•  Trials of Devices
•  Trials of Procedures

 

Based on Phase, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section. 
•  Phase I
•  Phase II
•  Phase III
•  Phase IV

 

By Design, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section. 
•  Interventional Studies
    o  Randomized Control Trial
    o  Adaptive Clinical Trial
    o  Non-randomized Control Trial
•  Observational Studies
    o  Cohort Study
    o  Case Control Study
    o  Cross Sectional Study
    o  Ecological Study
•  Expanded Access Trials

 

By Service Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section. 
•  Protocol Designing
•  Site Identification
•  Patient Recruitment
•  Laboratory Services
•  Bioanalytical Testing Services
•  Clinical Trial Data Management Services
•  Clinical Trial Supply & Logistic Services
•  Decentralized Clinical Trial Services
•  Medical Device Testing Services
•  Other Clinical Trial Services

 

By Indication, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section. 
•  Oncology
•  Infectious Diseases
•  Cardiology
•  Obesity
•  Diabetes
•  Neurology
•  Immunology
•  Pain Management
•  Other Indications

 

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section. 
•  Pharmaceutical and Biotechnological Companies
•  Clinical Research Organizations
•  Clinical Testing Laboratories
•  Other End Users

 

Geographically, the following regions together with the listed national/local markets are fully investigated:
•  North America (U.S., Canada, and Mexico)
•  Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
•  APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
•  South America (Brazil, Chile, Argentina, Rest of South America)
•  MEA (UAE, Saudi Arabia, South Africa and Rest of MEA)

 

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of all regional markets by country and split of each national market by Phase, Design, and Indication over the forecast years are also included. The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

 

Selected Key Players: 


Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
Phlexglobal
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc. 

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:

1 Introduction    12
1.1 Industry Definition and Research Scope    12
1.1.1 Industry Definition    12
1.1.2 Research Scope    13
1.2 Research Methodology    16
1.2.1 Overview of Market Research Methodology    16
1.2.2 Market Assumption    17
1.2.3 Secondary Data    17
1.2.4 Primary Data    17
1.2.5 Data Filtration and Model Design    18
1.2.6 Market Size/Share Estimation    19
1.2.7 Research Limitations    20
1.3 Executive Summary    21
2 Market Overview and Dynamics    24
2.1 Market Size and Forecast    24
2.1.1 Impact of COVID-19 on World Economy    26
2.1.2 Impact of COVID-19 on the Market    29
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery    31
2.2 Major Growth Drivers    35
2.3 Market Restraints and Challenges    42
2.4 Emerging Opportunities and Market Trends    45
2.5 Porter’s Fiver Forces Analysis    49
3 Segmentation of Global Market by Product Category    53
3.1 Market Overview by Product Category    53
3.2 Trials of Drugs    55
3.2.1 Small Molecule Drugs    56
3.2.2 Vaccines    57
3.2.3 Cell & Gene Therapy    58
3.2.4 Other Drugs    59
3.3 Trials of Devices    60
3.4 Trials of Procedures    61
4 Segmentation of Global Market by Phase    62
4.1 Market Overview by Phase    62
4.2 Phase I    64
4.3 Phase II    65
4.4 Phase III    66
4.5 Phase IV    67
5 Segmentation of Global Market by Design    68
5.1 Market Overview by Design    68
5.2 Interventional Studies    70
5.2.1 Randomized Control Trial    72
5.2.2 Adaptive Clinical Trial    73
5.2.3 Non-randomized Control Trial    74
5.3 Observational Studies    75
5.3.1 Cohort Study    77
5.3.2 Case Control Study    78
5.3.3 Cross Sectional Study    79
5.3.4 Ecological Study    80
5.4 Expanded Access Trials    81
6 Segmentation of Global Market by Service Type    82
6.1 Market Overview by Service Type    82
6.2 Protocol Designing    84
6.3 Site Identification    85
6.4 Patient Recruitment    86
6.5 Laboratory Services    87
6.6 Bioanalytical Testing Services    88
6.7 Clinical Trial Data Management Services    89
6.8 Clinical Trial Supply & Logistic Services    90
6.9 Decentralized Clinical Trial Services    91
6.10 Medical Device Testing Services    92
6.11 Other Clinical Trial Services    93
7 Segmentation of Global Market by Indication    94
7.1 Market Overview by Indication    94
7.2 Oncology    96
7.3 Infectious Diseases    97
7.4 Cardiology    98
7.5 Obesity    99
7.6 Diabetes    100
7.7 Neurology    101
7.8 Immunology    102
7.9 Pain Management    103
7.10 Other Indications    104
8 Segmentation of Global Market by End User    105
8.1 Market Overview by End User    105
8.2 Pharmaceutical and Biotechnological Companies    107
8.3 Clinical Research Organizations    108
8.4 Clinical Testing Laboratories    109
8.5 Other End Users    110
9 Segmentation of Global Market by Region    111
9.1 Geographic Market Overview 2021-2031    111
9.2 North America Market 2021-2031 by Country    115
9.2.1 Overview of North America Market    115
9.2.2 U.S.    119
9.2.3 Canada    122
9.2.4 Mexico    124
9.3 European Market 2021-2031 by Country    126
9.3.1 Overview of European Market    126
9.3.2 Germany    130
9.3.3 U.K.    132
9.3.4 France    134
9.3.5 Spain    136
9.3.6 Italy    138
9.3.7 Russia    140
9.3.8 Rest of European Market    142
9.4 Asia-Pacific Market 2021-2031 by Country    144
9.4.1 Overview of Asia-Pacific Market    144
9.4.2 Japan    148
9.4.3 China    151
9.4.4 Australia    153
9.4.5 India    155
9.4.6 South Korea    157
9.4.7 Rest of APAC Region    159
9.5 South America Market 2021-2031 by Country    161
9.5.1 Argentina    164
9.5.2 Brazil    166
9.5.3 Chile    168
9.5.4 Rest of South America Market    170
9.6 MEA Market 2021-2031 by Country    171
9.6.1 UAE    174
9.6.2 Saudi Arabia    176
9.6.3 South Africa    178
9.6.4 Other National Markets    180
10 Competitive Landscape    181
10.1 Overview of Key Vendors    181
10.2 New Product Launch, Partnership, Investment, and M&A    185
10.3 Company Profiles    186
Accell Clinical Research LLC    186
Charles River Laboratories    188
ClinDatrix Inc    191
Clinipace    192
Eli Lilly and Company    194
F. Hoffmann-La Roche Ltd.    197
ICON PLC    200
IQVIA Holdings, Inc.    203
Laboratory Corporation of America (Covance Inc.)    207
Novo Nordisk AS    211
PAREXEL International Corporation    214
Pfizer Inc.    218
Pharmaceutical Product Development LLC    223
Phlexglobal    226
PRA Health Sciences    228
Sanofi SA    230
SGS SA (SGS Life Sciences)    233
Syneos Health Inc.    236
Wuxi AppTec Inc.    239
RELATED REPORTS    241

 

List of Tables:

Table 1. Snapshot of Global Clinical Trials Market in Balanced Perspective, 2022-2031    22
Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-2021    25
Table 3. World Economic Outlook, 2021-2031    27
Table 4. World Economic Outlook, 2021-2023    28
Table 5. Scenarios for Economic Impact of Ukraine Crisis    32
Table 6. World Health Spending by Region, $ bn, 2013-2020    41
Table 7. Main Product Trends and Market Opportunities in Global Clinical Trials Market    45
Table 8. Global Clinical Trials Market by Product Category, 2021-2031, $ mn    53
Table 9. Global Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn    55
Table 10. Global Clinical Trials Market by Phase, 2021-2031, $ mn    62
Table 11. Global Clinical Trials Market by Design, 2021-2031, $ mn    68
Table 12. Global Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn    71
Table 13. Global Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn    76
Table 14. Global Clinical Trials Market by Service Type, 2021-2031, $ mn    82
Table 15. Global Clinical Trials Market by Indication, 2021-2031, $ mn    94
Table 16. Global Clinical Trials Market by End User, 2021-2031, $ mn    105
Table 17. Global Clinical Trials Market by Region, 2021-2031, $ mn    112
Table 18. Leading National Clinical Trials Market, 2022 and 2031, $ mn    114
Table 19. North America Clinical Trials Market by Country, 2021-2031, $ mn    117
Table 20. U.S. Clinical Trials Market by Phase, 2021-2031, $ mn    121
Table 21. U.S. Clinical Trials Market by Design, 2021-2031, $ mn    121
Table 22. U.S. Clinical Trials Market by Indication, 2021-2031, $ mn    121
Table 23. Canada Clinical Trials Market by Phase, 2021-2031, $ mn    123
Table 24. Canada Clinical Trials Market by Design, 2021-2031, $ mn    123
Table 25. Canada Clinical Trials Market by Indication, 2021-2031, $ mn    123
Table 26. Mexico Clinical Trials Market by Phase, 2021-2031, $ mn    125
Table 27. Mexico Clinical Trials Market by Design, 2021-2031, $ mn    125
Table 28. Mexico Clinical Trials Market by Indication, 2021-2031, $ mn    125
Table 29. Europe Clinical Trials Market by Country, 2021-2031, $ mn    129
Table 30. Germany Clinical Trials Market by Phase, 2021-2031, $ mn    131
Table 31. Germany Clinical Trials Market by Design, 2021-2031, $ mn    131
Table 32. Germany Clinical Trials Market by Indication, 2021-2031, $ mn    131
Table 33. U.K. Clinical Trials Market by Phase, 2021-2031, $ mn    133
Table 34. U.K. Clinical Trials Market by Design, 2021-2031, $ mn    133
Table 35. U.K. Clinical Trials Market by Indication, 2021-2031, $ mn    133
Table 36. France Clinical Trials Market by Phase, 2021-2031, $ mn    135
Table 37. France Clinical Trials Market by Design, 2021-2031, $ mn    135
Table 38. France Clinical Trials Market by Indication, 2021-2031, $ mn    135
Table 39. Spain Clinical Trials Market by Phase, 2021-2031, $ mn    137
Table 40. Spain Clinical Trials Market by Design, 2021-2031, $ mn    137
Table 41. Spain Clinical Trials Market by Indication, 2021-2031, $ mn    137
Table 42. Italy Clinical Trials Market by Phase, 2021-2031, $ mn    139
Table 43. Italy Clinical Trials Market by Design, 2021-2031, $ mn    139
Table 44. Italy Clinical Trials Market by Indication, 2021-2031, $ mn    139
Table 45. Russia Clinical Trials Market by Phase, 2021-2031, $ mn    141
Table 46. Russia Clinical Trials Market by Design, 2021-2031, $ mn    141
Table 47. Russia Clinical Trials Market by Indication, 2021-2031, $ mn    141
Table 48. Clinical Trials Market in Rest of Europe by Country, 2021-2031, $ mn    143
Table 49. APAC Clinical Trials Market by Country, 2021-2031, $ mn    146
Table 50. Japan Clinical Trials Market by Phase, 2021-2031, $ mn    150
Table 51. Japan Clinical Trials Market by Design, 2021-2031, $ mn    150
Table 52. Japan Clinical Trials Market by Indication, 2021-2031, $ mn    150
Table 53. China Clinical Trials Market by Phase, 2021-2031, $ mn    152
Table 54. China Clinical Trials Market by Design, 2021-2031, $ mn    152
Table 55. China Clinical Trials Market by Indication, 2021-2031, $ mn    152
Table 56. Australia Clinical Trials Market by Phase, 2021-2031, $ mn    154
Table 57. Australia Clinical Trials Market by Design, 2021-2031, $ mn    154
Table 58. Australia Clinical Trials Market by Indication, 2021-2031, $ mn    154
Table 59. India Clinical Trials Market by Phase, 2021-2031, $ mn    156
Table 60. India Clinical Trials Market by Design, 2021-2031, $ mn    156
Table 61. India Clinical Trials Market by Indication, 2021-2031, $ mn    156
Table 62. South Korea Clinical Trials Market by Phase, 2021-2031, $ mn    158
Table 63. South Korea Clinical Trials Market by Design, 2021-2031, $ mn    158
Table 64. South Korea Clinical Trials Market by Indication, 2021-2031, $ mn    158
Table 65. Clinical Trials Market in Rest of APAC by Country/Region, 2021-2031, $ mn    160
Table 66. South America Clinical Trials Market by Country, 2021-2031, $ mn    163
Table 67. Argentina Clinical Trials Market by Phase, 2021-2031, $ mn    165
Table 68. Argentina Clinical Trials Market by Design, 2021-2031, $ mn    165
Table 69. Argentina Clinical Trials Market by Indication, 2021-2031, $ mn    165
Table 70. Brazil Clinical Trials Market by Phase, 2021-2031, $ mn    167
Table 71. Brazil Clinical Trials Market by Design, 2021-2031, $ mn    167
Table 72. Brazil Clinical Trials Market by Indication, 2021-2031, $ mn    167
Table 73. Chile Clinical Trials Market by Phase, 2021-2031, $ mn    169
Table 74. Chile Clinical Trials Market by Design, 2021-2031, $ mn    169
Table 75. Chile Clinical Trials Market by Indication, 2021-2031, $ mn    169
Table 76. MEA Clinical Trials Market by Country, 2021-2031, $ mn    173
Table 77. UAE Clinical Trials Market by Phase, 2021-2031, $ mn    175
Table 78. UAE Clinical Trials Market by Design, 2021-2031, $ mn    175
Table 79. UAE Clinical Trials Market by Indication, 2021-2031, $ mn    175
Table 80. Saudi Arabia Clinical Trials Market by Phase, 2021-2031, $ mn    177
Table 81. Saudi Arabia Clinical Trials Market by Design, 2021-2031, $ mn    177
Table 82. Saudi Arabia Clinical Trials Market by Indication, 2021-2031, $ mn    177
Table 83. South Africa Clinical Trials Market by Phase, 2021-2031, $ mn    179
Table 84. South Africa Clinical Trials Market by Design, 2021-2031, $ mn    179
Table 85. South Africa Clinical Trials Market by Indication, 2021-2031, $ mn    179
Table 86. Percentage of Registered Studies by Location (as of February 24, 2022)    183
Table 87. Percentage of Recruiting Studies by Location (as of February 24, 2022)    183
Table 88. Accell Clinical Research LLC: Company Snapshot    186
Table 89. Accell Clinical Research LLC: Business Segmentation    187
Table 90. Accell Clinical Research LLC: Product Portfolio    187
Table 91. Charles River Laboratories: Company Snapshot    188
Table 92. Charles River Laboratories: Product Portfolio    189
Table 93. Charles River Laboratories: Breakdown of Revenue by Division    189
Table 94. Charles River Laboratories: Breakdown of Revenue by Region    190
Table 95. ClinDatrix Inc: Company Snapshot    191
Table 96. Clinipace: Company Snapshot    192
Table 97. Clinipace: Product Portfolio    193
Table 98. Eli Lilly and Company: Company Snapshot    194
Table 99. Eli Lilly and Company: Pharmaceutical Brands    195
Table 100. Eli Lilly and Company: Clinical Trial Service    195
Table 101. Eli Lilly and Company: Breakdown of Revenue by Therapeutic Area    195
Table 102. Eli Lilly and Company: Breakdown of Revenue by Region    196
Table 103. F. Hoffmann-La Roche: Company Snapshot    197
Table 104. F. Hoffmann-La Roche: Clinical Trial Service    197
Table 105. F. Hoffmann-La Roche: Business Segmentation    198
Table 106. F. Hoffmann-La Roche: Revenue by Region    198
Table 107. ICON Plc: Company Snapshot    200
Table 108. ICON Plc: Business Segmentation    200
Table 109. ICON Plc: Product Portfolio    201
Table 110. ICON Plc: Revenue by Region, 2020,  1
Table 111. IQVIA Holdings Inc.: Company Snapshot    203
Table 112. IQVIA Holdings Inc.: Business Segmentation    204
Table 113. IQVIA Holdings Inc.: Revenue by Region, 2020,  4
Table 114. IQVIA Holdings Inc.: Product Portfolio    205
Table 115. Covance Inc.: Company Snapshot    207
Table 116. Covance Inc.: Product Portfolio    208
Table 117. Covance Inc.: Revenue by Region, 2020,  9
Table 118. Novo Nordisk: Company Snapshot    211
Table 119. Novo Nordisk: Product Portfolio    212
Table 120. Novo Nordisk: Breakdown of Revenue by Business Segment    213
Table 121. Novo Nordisk: Breakdown of Revenue by Region    213
Table 122. PAREXEL International Corporation: Company Snapshot    214
Table 123. PAREXEL International Corporation: Business Segmentation    215
Table 124. PAREXEL International Corporation: Revenue by Region, 2018, !5
Table 125. PAREXEL International Corporation: Product Portfolio    216
Table 126. Pfizer Inc.: Company Snapshot    218
Table 127. Pfizer Inc.: Business Segmentation    219
Table 128. Pfizer Inc.: Breakdown of Revenue by Product Category    219
Table 129. Pfizer Inc.: Breakdown of Revenue by Region    220
Table 130. Pfizer Inc.: Product Portfolio    220
Table 131. Pfizer Inc.: Revenue, 2018-2020, $ bn    221
Table 132. Pharmaceutical Product Development LLC (PPD): Company Snapshot    223
Table 133. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Division    224
Table 134. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Region    224
Table 135. Phlexglobal: Company Snapshot    226
Table 136. PRA Health Sciences Inc.: Company Snapshot    228
Table 137. PRA Health Sciences Inc.: Business Segmentation    229
Table 138. PRA Health Sciences Inc.: Revenue by Region, 2018, "9
Table 139. Sanofi: Company Snapshot    230
Table 140. Sanofi: Business Segmentation    231
Table 141. Sanofi: Breakdown of Revenue by Region    231
Table 142. SGS SA (SGS Life Sciences): Company Snapshot    233
Table 143. SGS SA (SGS Life Sciences): Business Segmentation    234
Table 144. SGS SA (SGS Life Sciences): Revenue by Region, 2018, #4
Table 145. Syneos Health Inc.: Company Snapshot    236
Table 146. Syneos Health Inc.: Business Segmentation    237
Table 147. Syneos Health Inc.: Revenue by Region, 2020, #7
Table 148. WuXi AppTec Inc.: Company Snapshot    239

 

List of Figures:

Figure 1. Research Method Flow Chart    16
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation    19
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2031    21
Figure 4. Global Clinical Trials Market, 2021-2031, $ mn    24
Figure 5. Impact of COVID-19 on Business    29
Figure 6. Primary Drivers and Impact Factors of Global Clinical Trials Market    35
Figure 7. Percentage of Trial Participants by Country, 2015-2019    38
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million    39
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million    40
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060    40
Figure 11. Primary Restraints and Impact Factors of Global Clinical Trials Market    42
Figure 12. Investment Opportunity Analysis    46
Figure 13. Porter’s Fiver Forces Analysis of Global Clinical Trials Market    49
Figure 14. Breakdown of Global Clinical Trials Market by Product Category, 2021-2031, % of Revenue    54
Figure 15. Global Addressable Market Cap in 2023-2031 by Product Category, Value ($ mn) and Share (%)    54
Figure 16. Global Clinical Trials Market by Product Category: Trials of Drugs, 2021-2031, $ mn    55
Figure 17. Global Clinical Trials Market by Trials of Drugs: Small Molecule Drugs, 2021-2031, $ mn    56
Figure 18. Global Clinical Trials Market by Trials of Drugs: Vaccines, 2021-2031, $ mn    57
Figure 19. Global Clinical Trials Market by Trials of Drugs: Cell & Gene Therapy, 2021-2031, $ mn    58
Figure 20. Global Clinical Trials Market by Trials of Drugs: Other Drugs, 2021-2031, $ mn    59
Figure 21. Global Clinical Trials Market by Product Category: Trials of Devices, 2021-2031, $ mn    60
Figure 22. Global Clinical Trials Market by Product Category: Trials of Procedures, 2021-2031, $ mn    61
Figure 23. Breakdown of Global Clinical Trials Market by Phase, 2021-2031, % of Sales Revenue    63
Figure 24. Global Addressable Market Cap in 2023-2031 by Phase, Value ($ mn) and Share (%)    63
Figure 25. Global Clinical Trials Market by Phase: Phase I, 2021-2031, $ mn    64
Figure 26. Global Clinical Trials Market by Phase: Phase II, 2021-2031, $ mn    65
Figure 27. Global Clinical Trials Market by Phase: Phase III, 2021-2031, $ mn    66
Figure 28. Global Clinical Trials Market by Phase: Phase IV, 2021-2031, $ mn    67
Figure 29. Breakdown of Global Clinical Trials Market by Design, 2021-2031, % of Sales Revenue    69
Figure 30. Global Addressable Market Cap in 2023-2031 by Design, Value ($ mn) and Share (%)    69
Figure 31. Global Clinical Trials Market by Design: Interventional Studies, 2021-2031, $ mn    70
Figure 32. Global Clinical Trials Market by Interventional Studies: Randomized Control Trial, 2021-2031, $ mn    72
Figure 33. Global Clinical Trials Market by Interventional Studies: Adaptive Clinical Trial, 2021-2031, $ mn    73
Figure 34. Global Clinical Trials Market by Interventional Studies: Non-randomized Control Trial, 2021-2031, $ mn    74
Figure 35. Global Clinical Trials Market by Design: Observational Studies, 2021-2031, $ mn    75
Figure 36. Global Clinical Trials Market by Observational Studies: Cohort Study, 2021-2031, $ mn    77
Figure 37. Global Clinical Trials Market by Observational Studies: Case Control Study, 2021-2031, $ mn    78
Figure 38. Global Clinical Trials Market by Observational Studies: Cross Sectional Study, 2021-2031, $ mn    79
Figure 39. Global Clinical Trials Market by Observational Studies: Ecological Study, 2021-2031, $ mn    80
Figure 40. Global Clinical Trials Market by Design: Expanded Access Trials, 2021-2031, $ mn    81
Figure 41. Breakdown of Global Clinical Trials Market by Service Type, 2021-2031, % of Revenue    83
Figure 42. Global Addressable Market Cap in 2023-2031 by Service Type, Value ($ mn) and Share (%)    83
Figure 43. Global Clinical Trials Market by Service Type: Protocol Designing, 2021-2031, $ mn    84
Figure 44. Global Clinical Trials Market by Service Type: Site Identification, 2021-2031, $ mn    85
Figure 45. Global Clinical Trials Market by Service Type: Patient Recruitment, 2021-2031, $ mn    86
Figure 46. Global Clinical Trials Market by Service Type: Laboratory Services, 2021-2031, $ mn    87
Figure 47. Global Clinical Trials Market by Service Type: Bioanalytical Testing Services, 2021-2031, $ mn    88
Figure 48. Global Clinical Trials Market by Service Type: Clinical Trial Data Management Services, 2021-2031, $ mn    89
Figure 49. Global Clinical Trials Market by Service Type: Clinical Trial Supply & Logistic Services, 2021-2031, $ mn    90
Figure 50. Global Clinical Trials Market by Service Type: Decentralized Clinical Trial Services, 2021-2031, $ mn    91
Figure 51. Global Clinical Trials Market by Service Type: Medical Device Testing Services, 2021-2031, $ mn    92
Figure 52. Global Clinical Trials Market by Service Type: Other Clinical Trial Services, 2021-2031, $ mn    93
Figure 53. Breakdown of Global Clinical Trials Market by Indication, 2021-2031, % of Revenue    95
Figure 54. Global Addressable Market Cap in 2023-2031 by Indication, Value ($ mn) and Share (%)    95
Figure 55. Global Clinical Trials Market by Indication: Oncology, 2021-2031, $ mn    96
Figure 56. Global Clinical Trials Market by Indication: Infectious Diseases, 2021-2031, $ mn    97
Figure 57. Global Clinical Trials Market by Indication: Cardiology, 2021-2031, $ mn    98
Figure 58. Global Clinical Trials Market by Indication: Obesity, 2021-2031, $ mn    99
Figure 59. Global Clinical Trials Market by Indication: Diabetes, 2021-2031, $ mn    100
Figure 60. Global Clinical Trials Market by Indication: Neurology, 2021-2031, $ mn    101
Figure 61. Global Clinical Trials Market by Indication: Immunology, 2021-2031, $ mn    102
Figure 62. Global Clinical Trials Market by Indication: Pain Management, 2021-2031, $ mn    103
Figure 63. Global Clinical Trials Market by Indication: Other Indications, 2021-2031, $ mn    104
Figure 64. Breakdown of Global Clinical Trials Market by End User, 2021-2031, % of Revenue    105
Figure 65. Global Addressable Market Cap in 2023-2031 by End User, Value ($ mn) and Share (%)    106
Figure 66. Global Clinical Trials Market by End User: Pharmaceutical and Biotechnological Companies, 2021-2031, $ mn    107
Figure 67. Global Clinical Trials Market by End User: Clinical Research Organizations, 2021-2031, $ mn    108
Figure 68. Global Clinical Trials Market by End User: Clinical Testing Laboratories, 2021-2031, $ mn    109
Figure 69. Global Clinical Trials Market by End User: Other End Users, 2021-2031, $ mn    110
Figure 70. Global Market Snapshot by Region    111
Figure 71. Geographic Spread of Worldwide Clinical Trials Market, 2021-2031, % of Sales Revenue    112
Figure 72. Global Addressable Market Cap in 2023-2031 by Region, Value ($ mn) and Share (%)    113
Figure 73. North American Clinical Trials Market, 2021-2031, $ mn    116
Figure 74. Breakdown of North America Clinical Trials Market by Country, 2022 and 2031, % of Revenue    117
Figure 75. Contribution to North America 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)    118
Figure 76. U.S. Clinical Trials Market, 2021-2031, $ mn    120
Figure 77. Canada Clinical Trials Market, 2021-2031, $ mn    122
Figure 78. Clinical Trials Market in Mexico, 2021-2031, $ mn    124
Figure 79. European Clinical Trials Market, 2021-2031, $ mn    127
Figure 80. Breakdown of European Clinical Trials Market by Country, 2022 and 2031, % of Revenue    128
Figure 81. Contribution to Europe 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)    129
Figure 82. Clinical Trials Market in Germany, 2021-2031, $ mn    130
Figure 83. Clinical Trials Market in U.K., 2021-2031, $ mn    132
Figure 84. Clinical Trials Market in France, 2021-2031, $ mn    134
Figure 85. Clinical Trials Market in Spain, 2021-2031, $ mn    136
Figure 86. Clinical Trials Market in Italy, 2021-2031, $ mn    138
Figure 87. Clinical Trials Market in Russia, 2021-2031, $ mn    140
Figure 88. Clinical Trials Market in Rest of Europe, 2021-2031, $ mn    142
Figure 89. Asia-Pacific Clinical Trials Market, 2021-2031, $ mn    145
Figure 90. Breakdown of APAC Clinical Trials Market by Country, 2022 and 2031, % of Revenue    145
Figure 91. Contribution to APAC 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)    147
Figure 92. Clinical Trials Market in Japan, 2021-2031, $ mn    149
Figure 93. Clinical Trials Market in China, 2021-2031, $ mn    151
Figure 94. Clinical Trials Market in Australia, 2021-2031, $ mn    153
Figure 95. Clinical Trials Market in India, 2021-2031, $ mn    155
Figure 96. Clinical Trials Market in South Korea, 2021-2031, $ mn    157
Figure 97. Clinical Trials Market in Rest of APAC, 2021-2031, $ mn    159
Figure 98. South America Clinical Trials Market, 2021-2031, $ mn    162
Figure 99. Breakdown of South America Clinical Trials Market by Country, 2022 and 2031, % of Revenue    162
Figure 100. Contribution to South America 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)    163
Figure 101. Clinical Trials Market in Argentina, 2021-2031, $ mn    164
Figure 102. Clinical Trials Market in Brazil, 2021-2031, $ mn    166
Figure 103. Clinical Trials Market in Chile, 2021-2031, $ mn    168
Figure 104. Clinical Trials Market in Rest of South America, 2021-2031, $ mn    170
Figure 105. Clinical Trials Market in Middle East and Africa (MEA), 2021-2031, $ mn    172
Figure 106. Breakdown of MEA Clinical Trials Market by Country, 2022 and 2031, % of Revenue    172
Figure 107. Contribution to MEA 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)    173
Figure 108. Clinical Trials Market in UAE, 2021-2031, $ mn    174
Figure 109. Clinical Trials Market in Saudi Arabia, 2021-2031, $ mn    176
Figure 110. Clinical Trials Market in South Africa, 2021-2031, $ mn    178
Figure 111. Growth Stage of Global Clinical Trials Industry over the Forecast Period    181
Selected Key Players:

Accell Clinical Research LLC
Charles River Laboratory
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PRA Health Sciences
Sanofi SA
SGS SA
Syneos Health Inc.
Wuxi AppTec Inc. 

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)